PT Indofarma Tbk (ISX:INAF) Additional Paid-In Capital : Rp81,120 Mil(As of Sep. 2023)

View and export this data going back to 2001. Start your Free Trial

What is PT Indofarma Tbk Additional Paid-In Capital?

PT Indofarma Tbk's quarterly additional paid-in capital stayed the same from Mar. 2023 (Rp81,120 Mil) to Jun. 2023 (Rp81,120 Mil) and stayed the same from Jun. 2023 (Rp81,120 Mil) to Sep. 2023 (Rp81,120 Mil).

PT Indofarma Tbk's annual additional paid-in capital stayed the same from Dec. 2020 (Rp81,120 Mil) to Dec. 2021 (Rp81,120 Mil) and stayed the same from Dec. 2021 (Rp81,120 Mil) to Dec. 2022 (Rp81,120 Mil).

PT Indofarma Tbk Additional Paid-In Capital Historical Data

The historical data trend for PT Indofarma Tbk's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Indofarma Tbk Additional Paid-In Capital Chart

PT Indofarma Tbk Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Additional Paid-In Capital

Get a 7-Day Free Trial

81,120.06

PT Indofarma Tbk Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Additional Paid-In Capital	Get a 7-Day Free Trial															81,120.06	81,120.06	81,120.06	81,120.06	81,120.06

PT Indofarma Tbk Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

PT Indofarma Tbk Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of PT Indofarma Tbk's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Indofarma Tbk (ISX:INAF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Indofarma Tbk (ISX:INAF) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jalan Indofarma No. 1, Cikarang Barat, Jawa Bara, Bekasi, IDN, 17530

Website

http://www.indofarma.id

PT Indofarma Tbk is a specialty and generic drug manufacturing company. The company has four business segments - Medicine, Medical Devices and others, Pharmaceutical Engineering, and Aliansi Strategis Segment. The Medicine business segment includes drug production, marketing and distribution and sales. The Medical Device Segment includes medical devices and other products. The Pharmaceutical Engineering Segment includes the sale and maintenance of packaging machines for the pharmaceutical industry to external parties.

PT Indofarma Tbk (ISX:INAF) Headlines

No Headlines